158 related articles for article (PubMed ID: 12004326)
41. Coexistence of psoriasis and an unusual IgG-mediated subepidermal bullous dermatosis: identification of a novel 200-kDa lower lamina lucida target antigen.
Chen KR; Shimizu S; Miyakawa S; Ishiko A; Shimizu H; Hashimoto T
Br J Dermatol; 1996 Feb; 134(2):340-6. PubMed ID: 8746353
[TBL] [Abstract][Full Text] [Related]
42. Subepidermal blistering disease with 3 distinct autoantibodies: anti-BP230, anti-laminin gamma-1, and anti-laminin-332.
Kikuchi K; Natsuga K; Shinkuma S; Nishie W; Kajita S; Sato H; Shimizu H
J Am Acad Dermatol; 2011 Oct; 65(4):878-880. PubMed ID: 21920249
[No Abstract] [Full Text] [Related]
43. Diagnosis and classification of pemphigus and bullous pemphigoid.
Kershenovich R; Hodak E; Mimouni D
Autoimmun Rev; 2014; 13(4-5):477-81. PubMed ID: 24424192
[TBL] [Abstract][Full Text] [Related]
44. Changes in the autoimmune blistering response: a clinical and immunopathological shift from pemphigus foliaceus to bullous pemphigoid.
Maeda JY; Moura AK; Maruta CW; Santi CG; Prisayanh PS; Aoki V
Clin Exp Dermatol; 2006 Sep; 31(5):653-5. PubMed ID: 16901304
[TBL] [Abstract][Full Text] [Related]
45. Lichen planus pemphigoides with IgG autoantibodies to the 180 kd bullous pemphigoid antigen (type XVII collagen).
Hsu S; Ghohestani RF; Uitto J
J Am Acad Dermatol; 2000 Jan; 42(1 Pt 1):136-41. PubMed ID: 10607335
[TBL] [Abstract][Full Text] [Related]
46. Autoantibodies from patients with localized and generalized bullous pemphigoid immunoprecipitate the same 230-kd keratinocyte antigen.
Domloge-Hultsch N; Utecht L; James W; Yancey KB
Arch Dermatol; 1990 Oct; 126(10):1337-41. PubMed ID: 2221940
[TBL] [Abstract][Full Text] [Related]
47. A subepidermal blistering disease with histopathological features of dermatitis herpetiformis and immunofluorescence characteristics of bullous pemphigoid: a novel subepidermal blistering disease or a variant of bullous pemphigoid?
Salmhofer W; Kawahara Y; Soyer HP; Kerl H; Nishikawa T; Hashimoto T
Br J Dermatol; 1997 Oct; 137(4):599-604. PubMed ID: 9390339
[TBL] [Abstract][Full Text] [Related]
48. Childhood vulval pemphigoid: a clinical and immunopathological study of five patients.
Farrell AM; Kirtschig G; Dalziel KL; Allen J; Dootson G; Edwards S; Wojnarowska F
Br J Dermatol; 1999 Feb; 140(2):308-12. PubMed ID: 10233228
[TBL] [Abstract][Full Text] [Related]
49. Bullous Pemphigoid: A Review of its Diagnosis, Associations and Treatment.
Bernard P; Antonicelli F
Am J Clin Dermatol; 2017 Aug; 18(4):513-528. PubMed ID: 28247089
[TBL] [Abstract][Full Text] [Related]
50. Clinical and immunological features and outcome of anti-p200 pemphigoid.
Commin MH; Schmidt E; Duvert-Lehembre S; Lasek A; Morice C; Estival JL; Debarbieux S; Rigal E; Pauwels C; De Quatrebarbes J; Roussel A; Goujon E; Stoebner PE; Jouen F; Joly P
Br J Dermatol; 2016 Oct; 175(4):776-81. PubMed ID: 27037896
[TBL] [Abstract][Full Text] [Related]
51. Bullous pemphigoid positive for anti-BP180 and anti-laminin 5 antibodies in a patient with graft-vs-host disease.
Izumi R; Fujimoto M; Yazawa N; Nakashima H; Asashima N; Watanabe R; Kuwano Y; Kurokawa M; Hashimoto T; Tamaki K
J Am Acad Dermatol; 2007 May; 56(5 Suppl):S94-7. PubMed ID: 17434049
[TBL] [Abstract][Full Text] [Related]
52. Transition from pemphigus foliaceus to bullous pemphigoid: intermolecular B-cell epitope spreading without IgG subclass shifting.
Recke A; Rose C; Schmidt E; Bröcker EB; Zillikens D; Sitaru C
J Am Acad Dermatol; 2009 Aug; 61(2):333-6. PubMed ID: 19615544
[TBL] [Abstract][Full Text] [Related]
53. U-serrated immunodeposition pattern differentiates type VII collagen targeting bullous diseases from other subepidermal bullous autoimmune diseases.
Vodegel RM; Jonkman MF; Pas HH; de Jong MC
Br J Dermatol; 2004 Jul; 151(1):112-8. PubMed ID: 15270879
[TBL] [Abstract][Full Text] [Related]
54. Canine bullous pemphigoid (BP): identification of the 180-kd canine BP antigen by circulating autoantibodies.
Iwasaki T; Olivry T; Lapiere JC; Chan LS; Peavey C; Liu YY; Jones JC; Ihrke PJ; Woodley DT
Vet Pathol; 1995 Jul; 32(4):387-93. PubMed ID: 7483213
[TBL] [Abstract][Full Text] [Related]
55. Bullous pemphigoid: from the clinic to the bench.
Di Zenzo G; Della Torre R; Zambruno G; Borradori L
Clin Dermatol; 2012; 30(1):3-16. PubMed ID: 22137222
[TBL] [Abstract][Full Text] [Related]
56. A case of subepidermal blistering disease with autoantibodies to multiple laminin subunits who developed later autoantibodies to alpha-5 chain of type IV collagen associated with membranous glomerulonephropathy.
Sueki H; Sato Y; Ohtoshi S; Nakada T; Yoshimura A; Tateishi C; Borza DB; Fader W; Ghohestani RF; Hirako Y; Koga H; Ishii N; Tsuchisaka A; Qian H; Li X; Hashimoto T
Acta Derm Venereol; 2015 Sep; 95(7):826-9. PubMed ID: 25633161
[TBL] [Abstract][Full Text] [Related]
57. A severe and refractory case of anti-p200 pemphigoid resulting in multiple skin ulcers and scar formation.
Goto-Ohguchi Y; Nishie W; Akiyama M; Tateishi Y; Aoyagi S; Tsuji-Abe Y; Sawamura D; Ishii N; Hashimoto T; Shimizu H
Dermatology; 2009; 218(3):265-71. PubMed ID: 19060472
[TBL] [Abstract][Full Text] [Related]
58. Pemphigoid with antibodies to laminin γ1, BP180 and BP230, associated with psoriasis vulgaris: successful disease control with cyclosporin.
Imanishi A; Tateishi C; Imanishi H; Sowa-Osako J; Koga H; Tsuruta D; Hashimoto T
J Dermatol; 2015 Apr; 42(4):394-7. PubMed ID: 25708520
[TBL] [Abstract][Full Text] [Related]
59. Bullous pemphigoid in a 3-month-old infant after vaccination.
Cortés-Pinto C; Baradad Brusau M; Vilardell Vilellas F; Mascaró Galy JM; Arco Huguet N; Soria Gili X
Clin Exp Dermatol; 2019 Apr; 44(3):341-343. PubMed ID: 30267442
[No Abstract] [Full Text] [Related]
60. Childhood bullous pemphigoid: report of a case with characterization of the targeted antigens.
Trüeb RM; Didierjean L; Fellas A; Elias A; Borradori L
J Am Acad Dermatol; 1999 Feb; 40(2 Pt 2):338-44. PubMed ID: 10025864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
